Lilly's (LLY) Alimta ANDA Receives FDA Paragraph IV Certification

October 15, 2012 2:53 PM EDT Send to a Friend
The FDA has given Eli Lilly's (NYSE: LLY) Alimta its Paragraph IV certification, according to the agency.

Lilly submitted its ANDA for Alimta on June 27, 2012. The submission was made for the 1000-mg vial.

Shares of Lilly are up 3 percent Monday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Fed

Add Your Comment